Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (11-20 of 570) with videos related to

Pageof 57
Sort By:
Pharmaceutical Patent Analyst|November 19, 2013
Metabotropic glutamate receptor 5-positive allosteric modulators for the treatment of schizophrenia (2004-2012)Craig W Lindsley, Shaun R Stauffer
Current Opinion in Drug Discovery & Development|June 30, 2009
Recent progress in the discovery and development of negative allosteric modulators of mGluR5Craig W Lindsley, Kyle A Emmitte
ACS Chemical Neuroscience|July 9, 2020
<b></b> Classics in Chemical Neuroscience: U-47700Kwaku Kyei-Baffour, Craig W Lindsley
Organic Letters|May 24, 2012
A general, enantioselective synthesis of protected morpholines and piperazinesMatthew C O'Reilly, Craig W Lindsley
Psychopharmacology|September 11, 2001
Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaqueD C Javitt, R W Lindsley
ACS Chemical Neuroscience|September 20, 2013
Classics in chemical neuroscience: clozapineCody J Wenthur, Craig W Lindsley
ACS Chemical Neuroscience|April 27, 2018
Classics in Chemical Neuroscience: RisperidoneTrevor C Chopko, Craig W Lindsley
Organic Letters|September 28, 2011
Highly diastereoselective and general synthesis of primary β-fluoroaminesMichael L Schulte, Craig W Lindsley
ACS Chemical Biology|July 26, 2008
G-protein-coupled receptors: from classical modes of modulation to allosteric mechanismsThomas M Bridges, Craig W Lindsley
Current Topics in Medicinal Chemistry|May 19, 2007
Small molecule protein-protein inhibitors for the p53-MDM2 interactionAnna S Dudkina, Craig W Lindsley
Pageof 57

Showing results (11-20 of 570) with videos related to

Sort By:
Pageof 57
Pharmaceutical Patent Analyst|November 19, 2013
Metabotropic glutamate receptor 5-positive allosteric modulators for the treatment of schizophrenia (2004-2012)Craig W Lindsley, Shaun R Stauffer
Current Opinion in Drug Discovery & Development|June 30, 2009
Recent progress in the discovery and development of negative allosteric modulators of mGluR5Craig W Lindsley, Kyle A Emmitte
ACS Chemical Neuroscience|July 9, 2020
<b></b> Classics in Chemical Neuroscience: U-47700Kwaku Kyei-Baffour, Craig W Lindsley
Organic Letters|May 24, 2012
A general, enantioselective synthesis of protected morpholines and piperazinesMatthew C O'Reilly, Craig W Lindsley
Psychopharmacology|September 11, 2001
Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaqueD C Javitt, R W Lindsley
ACS Chemical Neuroscience|September 20, 2013
Classics in chemical neuroscience: clozapineCody J Wenthur, Craig W Lindsley
ACS Chemical Neuroscience|April 27, 2018
Classics in Chemical Neuroscience: RisperidoneTrevor C Chopko, Craig W Lindsley
Organic Letters|September 28, 2011
Highly diastereoselective and general synthesis of primary β-fluoroaminesMichael L Schulte, Craig W Lindsley
ACS Chemical Biology|July 26, 2008
G-protein-coupled receptors: from classical modes of modulation to allosteric mechanismsThomas M Bridges, Craig W Lindsley
Current Topics in Medicinal Chemistry|May 19, 2007
Small molecule protein-protein inhibitors for the p53-MDM2 interactionAnna S Dudkina, Craig W Lindsley
Pageof 57